CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2018

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Effect of oral palonosetron in improving quality of life as compared to other oral 5ht-3 antagonists in delayed cinv in patients of breast cancer

Author: 
Dr. Abhishek Shrivastava, Dr. Supriya Sharma and Dr. Arun Kumar Shrivastava
Subject Area: 
Health Sciences
Abstract: 

Introduction: The primary objective was to prevent delayed chemo induced nausea and vomiting (CINV). The primary efficacy end point was complete Response (CR) and improving quality of life (QOL). Material and Methods: This is a prospective, observational study conducted on 45 previously untreated histopathologically-proven patients of ductal carcinoma of Breast from January to December 2015. In this study the patients were selected based on our inclusion criteria and each cohort was composed of 15 breast carcinoma diagnosed patients, each cohort receiving Oral Ondansetron 4 mg TDS(cohort 1) ; Oral Granisetron 1 mg BD(cohort 2) ;Oral Palonosetron 0.5 mg OD(cohort 3)and after standard protocol based chemotherapy from day 3 to day 7 post chemotherapy for the prevention of Delayed CINV. and were asked to keep a vomiting diary ,interviewed on telephone and on next follow up visit and then results were graded according to the response obtained by each individual. Patients with history of allergy to 5HT-3antagonists, any associated medical condition causing nausea/vomiting were excluded. Results: A total 165 patients were included in the study, In Palonosetron Cohort 98% patients of H&N have CR and 33% in Cx in Cisplatin based chemotherapy and 64%in Anthracyclin based chemotherapy in Breast Cancer patients. Granisetron Cohort; H& N 53%, Cx 22%. Breast 84%. Ondensetron Cohort; H&N 29%, Cx 13 % Breast 57%. Conclusion: This study shows that oral Palonosetron is better than other oral 5HT-3 antagonists to prevent delayed CINV and thereby improving QOL in patients on chemotherapy.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran